CHRNA5 promoted DNA replication, reduced cell adhesion, suppressed antigen presentation, and induced hypomethylation and miRNA overexpression (bioinformatics analyses), and also attenuated epithelial features and enhanced mesenchymal traits, ultimately leading to a disseminated tumor pattern, a worse clinical stage, and a poor prognosis. This evidence concerns the gene CHRNA5 and neoplasm.